SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-235380
Filing Date
2019-08-30
Accepted
2019-08-30 17:13:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d788934ds3a.htm S-3/A 532554
2 EX-23.1 d788934dex231.htm EX-23.1 2455
3 GRAPHIC g788934g57j37.jpg GRAPHIC 33539
  Complete submission text file 0001193125-19-235380.txt   582226
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-233448 | Film No.: 191070224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences